Published: Sunday, January 3, 2021, 8:28 [IST]
New Delhi, Jan 03: Some of the issues flagged during the dry run of the COVID-19 vaccine drive were additional staff, better internet connectivity and more time to manage adverse events.
In the national capital, where the dry run was held at three sites, Delhi Health Minister Satyendar Jain said that free coronavirus vaccine will be provided to the people in the city. Interacting with reporters during a visit to a facility in Daryaganj, he said the system seems flawless as of now.
The dry run involved 286 session sites spread across 125 districts. India has reported 1.03 crore COVID-19 cases so far and the exercise was held on a day an expert panel of the central drug authority recommended granting permission for restricted emergency use of the indigenously developed COVID-19 vaccine, Covaxin, with certain conditions, after giving similar direction for the Oxford vaccine Covishield.
Highlights: Covid-19 vaccination dry run begins across India
Premium
1 min read
Share Via
Read Full Story
A dry run for covid-19 vaccination is being conducted by all state and union territory administrations today to test the linkages between planning and implementation and to identify the challenges
The activity is being conducted in all state capitals in at least 3 session sites.
TRENDING STORIESSee All
2 min read
Premium
UP: Schools shut till 15 May; night curfew hours extended in Noida, Lucknow, other districts. Details here
1 min read
Premium
2 min read
Premium
1 min read
Here are the highlights on the dry run for covid-19 vaccination program:
SEC recommends Bharat Biotech s COVAXIN for emergency use as India tests its vaccine delivery system The recommendation for Bharat Biotech s vaccine came a day after the COVID-19 expert panel cleared the Serum Institute of India s emergency use authorisation application for the Oxford-AstraZeneca vaccine Covishield FP Staff January 02, 2021 22:38:41 IST Representational image. AP expert panel of the CDSCO on Saturday recommended a second COVID-19 vaccine COVAXIN, indigenously developed by Bharat Biotech and the ICMR, for emergency use authorisation, especially against the mutant strains. The SEC’s recommendations will now be considered by the Drugs Controller General of India (DCGI), who will grant the final approval, reports said.
An identity check at the gate, a placebo injection in the vaccination room and a 30-minute wait in the observation room to note any adverse effect these were three crucial steps of the dry run for Covid-19 vaccines conducted in three places of Bengal on Saturday.
Seventy-five front line workers volunteered as recipients of the placebo during the dry run conducted at an urban primary health centre of the Bidhannagar Municipal Corporation at Salt Lake’s Duttabad, at the Amdanga Rural Hospital in North 24-Parganas and another urban primary health centre of Madhyamgram municipality. There were 25 volunteers at each of the sites.